SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-009964
Filing Date
2023-05-15
Accepted
2023-05-15 17:21:05
Documents
57
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20230331x10q.htm   iXBRL 10-Q 918878
2 EX-31.1 tmb-20230331xex31d1.htm EX-31.1 10596
3 EX-31.2 tmb-20230331xex31d2.htm EX-31.2 10444
4 EX-32.1 tmb-20230331xex32d1.htm EX-32.1 6674
5 EX-32.2 tmb-20230331xex32d2.htm EX-32.2 6351
  Complete submission text file 0001558370-23-009964.txt   4149139

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20230331.xsd EX-101.SCH 30569
7 EX-101.CAL tmb-20230331_cal.xml EX-101.CAL 31280
8 EX-101.DEF tmb-20230331_def.xml EX-101.DEF 119663
9 EX-101.LAB tmb-20230331_lab.xml EX-101.LAB 292168
10 EX-101.PRE tmb-20230331_pre.xml EX-101.PRE 218801
51 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20230331x10q_htm.xml XML 666714
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36020 | Film No.: 23924423
SIC: 2834 Pharmaceutical Preparations